Last C$0.40 CAD
Change Today 0.00 / 0.00%
Volume 31.3K
TPI On Other Exchanges
Symbol
Exchange
Venture
Munich
As of 3:30 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

t-bird pharma inc (TPI) Snapshot

Open
C$0.39
Previous Close
C$0.40
Day High
C$0.40
Day Low
C$0.35
52 Week High
09/9/14 - C$0.95
52 Week Low
01/29/15 - C$0.35
Market Cap
18.2M
Average Volume 10 Days
25.2K
EPS TTM
C$-0.15
Shares Outstanding
46.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for T-BIRD PHARMA INC (TPI)

Related News

No related news articles were found.

t-bird pharma inc (TPI) Related Businessweek News

No Related Businessweek News Found

t-bird pharma inc (TPI) Details

T-Bird Pharma Inc. operates as a pharmaceutical company in Canada. It primarily focuses on developing medical marijuana products. The company is based in White City, Canada.

t-bird pharma inc (TPI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

t-bird pharma inc (TPI) Key Developments

T-Bird Pharma Inc. Announces Executive Changes

T-Bird Pharma Inc. announced that Sandra (Sandy) Pratt has joined the Company as Chief Financial Officer, replacing Chris Taylor who has stepped down to return to his private practice. Taylor will remain involved with the Company at the Board level by continuing on as Corporate Secretary and operationally as an RPIC and consultant. More recently, Ms. Pratt served as Vice-President of Finance at the Oak Bay Marine Group.

T-Bird Pharma Inc. Announces Management Changes

T-Bird Pharma Inc. announced that Robert Gagnon has stepped down as CEO and Board member. Dr. Bin Huang, who joined the Company last Fall as President and Chief Operating Officer, has been appointed CEO in his place. Gagnon will be retained by the Company as a consultant for a period of one year. Since joining T-Bird Dr. Huang has been instrumental in applying pharma processes to the company's operations as well as readying the Company for scalable growth.

T-Bird Pharma Inc. Appoints Bin Huang as President and Chief Operating Officer

T-Bird Pharma Inc. announced that Dr. Bin Huang has joined the company as President and Chief Operating Officer. Dr. Huang joins the company as a key part of its growth and commercialization strategy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TPI:CN C$0.40 CAD 0.00

TPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TPI.
View Industry Companies
 

Industry Analysis

TPI

Industry Average

Valuation TPI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T-BIRD PHARMA INC, please visit www.tbirdpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.